Evidence map›Paper›PMID 32352019›Full record

ArticleJournal of immunology research2020

Interferon Kappa Is Important for Keratinocyte Host Defense against Herpes Simplex Virus-1.

Yuanyuan Li, Yueqi Song, Leqing Zhu, Xiao Wang, Brittany Richers, Donald Y M Leung, Lianghua Bin

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Immunomodulatory Role of Interferons in Viral and Bacterial Infections.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Superior antiviral activity of IFNβ in genital HSV-1 infection.Frontiers in cellular and infection microbiology · 2022
    Article
  10. Review
  11. Herpes Simplex Virus Type 1 Interactions with the Interferon System.International journal of molecular sciences · 2020
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yuanyuan LiBiomedical Translational Research Institute, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong Province, China.
Yueqi SongBiomedical Translational Research Institute, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong Province, China.
Leqing ZhuBiomedical Translational Research Institute, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong Province, China.
Xiao WangBiomedical Translational Research Institute, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong Province, China.
Brittany RichersDepartment of Pediatrics, National Jewish Health, Denver, Colorado, USA.
Donald Y M LeungDepartment of Pediatrics, National Jewish Health, Denver, Colorado, USA.
Lianghua BinDepartment of Pediatrics, National Jewish Health, Denver, Colorado, USA.ORCID https://orcid.org/0000-0002-3786-0106
First Affiliated Hospital of Jinan University · CNNational Jewish Health · US

Funding

THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASER01AR041256 · NIAMS · NATIONAL JEWISH HEALTH · PI GOLEVA, ELENA, LEUNG, DONALD YM · 1992 to 2020
$5.9M
NIAMS NIH HHS R01 AR041256
6 · The paper itself

Abstract

Type I interferon kappa (IFN

Indexed as

Cell DifferentiationCell LineHerpes SimplexHerpesvirus 1, HumanHumansImmunity, InnateInterferon Type IKeratinocytesPoly I-CRNA, Small InterferingSkinUp-RegulationVirus Replicationinterferon kappaInterferon Type IPoly I-CRNA, Small Interfering

Identifiers

PMID32352019
PMCPMC7178474
OpenAlexW2997161604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.